SUSQUEHANNA INTERNATIONAL GROUP, LLP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$139,718
-23.4%
160,602
-1.4%
0.00%
Q2 2023$182,381
+9.7%
162,840
+1.8%
0.00%
Q1 2023$166,279
+140.2%
159,884
+158.7%
0.00%
Q4 2022$69,220
-79.9%
61,804
-79.7%
0.00%
Q3 2022$345,000
-35.5%
304,919
-16.3%
0.00%
Q2 2022$535,000
-22.8%
364,210
+20.4%
0.00%
Q1 2022$693,000
-83.8%
302,438
-80.6%
0.00%
Q4 2021$4,284,000
-31.9%
1,558,500
+48.6%
0.00%
Q3 2021$6,294,000
+209.3%
1,048,909
+151.0%
0.00%
Q2 2021$2,035,000
+151.9%
417,955
+27.7%
0.00%
Q1 2021$808,000
+445.9%
327,380
+502.8%
0.00%
Q4 2020$148,000
+311.1%
54,314
+130.9%
0.00%
Q3 2020$36,000
-91.0%
23,524
-89.0%
0.00%
Q2 2020$401,000
-73.4%
213,082
-75.9%
0.00%
Q1 2020$1,505,000
+22.1%
885,274
+108.2%
0.00%
Q4 2019$1,233,000
+4303.6%
425,160
+1522.7%
0.00%
Q4 2018$28,000
-97.5%
26,200
-85.7%
0.00%
Q3 2018$1,125,000
-7.7%
183,021
+60.4%
0.00%
Q2 2018$1,219,000
+66.5%
114,100
+67.3%
0.00%
Q1 2018$732,000
+525.6%
68,200
+421.8%
0.00%
Q4 2016$117,00013,0700.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders